Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trial
Fragoso-Saavedra, Sergio, Núñez, Isaac, Audelo-Cruz, Belem M., Arias-Martínez, Sarahi, Manzur-Sandoval, Daniel, Quintero-Villegas, Alejandro, Benjamín García-González, H., Carbajal-Morelos, Sergio L., PoncedeLeón-Rosales, Sergio, Gotés-Palazuelos, José, Maza-Larrea, José A., Rosales-de la Rosa, J. Javier, Diaz-Rivera, Dafne, Luna-García, Edgar, Piten-Isidro, Elvira, Del Río-Estrada, Perla M., Fragoso-Saavedra, Mario, Caro-Vega, Yanink, Batina, Isabella, Islas-Weinstein, León, Iruegas-Nunez, David A., Calva, Juan J., Belaunzarán-Zamudio, Pablo F., Sierra-Madero, Juan, Crispín, José C., Valdés-Ferrer, Sergio Iván
Published in Molecular medicine (Cambridge, Mass.) (08.11.2022)
Published in Molecular medicine (Cambridge, Mass.) (08.11.2022)
Get full text
Journal Article
A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol
Fragoso-Saavedra, Sergio, Iruegas-Nunez, David A, Quintero-Villegas, Alejandro, García-González, H Benjamín, Nuñez, Isaac, Carbajal-Morelos, Sergio L, Audelo-Cruz, Belem M, Arias-Martínez, Sarahi, Caro-Vega, Yanink, Calva, Juan José, Luqueño-Martínez, Verónica, González-Duarte, Alejandra, Crabtree-Ramírez, Brenda, Crispín, José C, Sierra-Madero, Juan, Belaunzarán-Zamudio, Pablo F, Valdés-Ferrer, Sergio I
Published in BMC infectious diseases (16.10.2020)
Published in BMC infectious diseases (16.10.2020)
Get full text
Journal Article